Inventor · disambiguated record
Rudy Laurent Maria Broeckx
Also filed as: BROECKX RUDY · BROECKX RUDY LAURENT MARIA
16 granted patents·3 pending applications·110 citations·filing 2002–2023
93Inventor score
Top patents by PatentIndex Score
19 records- 0197US9108950B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2012·Granted Aug 18, 2015·38 cites·13 claims
- 0292US10738032B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2019·Granted Aug 11, 2020·3 cites·24 claims
- 0391US10266519B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Apr 23, 2019·6 cites·11 claims
- 0489US7572916B2Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinolineJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Aug 11, 2009·8 cites·10 claims
- 0589US7524961B2Diastereoselective addition of lithiated N-methylimidazole on sulfiniminesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Apr 28, 2009·8 cites·8 claims
- 0688US9850231B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Dec 26, 2017·5 cites·8 claims
- 0787US9227977B2Phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Jan 5, 2016·4 cites·7 claims
- 0887US7456287B2Diastereoselective synthesis process for the preparation of imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Nov 25, 2008·11 cites·10 claims
- 0984US8440863B2Preparation of (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentanamineFILLIERS WALTER FERDINAND MARIA·Filed 2012·Granted May 14, 2013·3 cites·3 claims
- 1080US2024343711A11-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase inhibitorsRESPIVERT LTD·Filed 2023·Application pending·0 cites
- 1177US6844439B2Process for the preparation of imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Jan 18, 2005·9 cites·10 claims
- 1274US8138376B2Preparation of (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentanamineFILLIERS WALTER FERDINAND MARIA·Filed 2007·Granted Mar 20, 2012·2 cites·10 claims
- 1369US6919459B2Process for preparing benzimidazole-type compoundsFiled 2002·Granted Jul 19, 2005·12 cites·14 claims
- 1466US9642799B2Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-0X0-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamideRESPIVERT LTD·Filed 2013·Granted May 9, 2017·1 cites·18 claims
- 1560US9556184B2Phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Jan 31, 2017·0 cites·3 claims
- 1658US9745306B22-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl) quinazolin-4(3H)-one derivatives and their use as phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Aug 29, 2017·0 cites·15 claims
- 1748US9056850B2Process for the preparation of compounds useful as inhibitors of SGLTFILLIERS WALTER FERDINAND MARIA·Filed 2009·Granted Jun 16, 2015·0 cites·31 claims
- 1847US2017334919A12-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoro-met hyl)benzyl)quinazolin-4(3h)-one derivatives and their use as phosphoinositide 3-kinase inhibitorsRESPIVERT LTD·Filed 2017·Application pending·0 cites
- 1942US2017239256A1CRYSTALLINE Pl3 KINASE INHIBITORSRESPIVERT LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →